Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure

ESC Heart Failure

Volumn 2, Issue 2, 2015, Pages 85-89

  Doehner, Wolfram ^a,b   Turhan, Guelistan ^c   Leyva, Francisco ^a   Rauchhaus, Mathias ^c   Sandek, Anja ^c   Jankowska, Ewa A ^d   von Haehling, Stephan ^e   Anker, Stefan D ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Chronic heart failure; Insulin sensitivity; Skeletal muscle

Indexed keywords

EID: 84995772118     PISSN: None     EISSN: 20555822     Source Type: Journal    
DOI: 10.1002/ehf2.12035     Document Type: Article

References (26)

1. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85:1364–73.
2. Doehner W, Frenneaux M, Anker SD. Metabolic impairment in heart failure: the myocardial and systemic perspective. J Am Coll Cardiol 2014; 64: 1388–400.
3. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81:518–27.
4. Brassard P, Maltais F, Noel M, Doyon JF, LeBlanc P, Allaire J, Simard C, Leblanc MH, Poirier P, Jobin J. Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure. Can J Cardiol 2006; 22: 387–92.
5. Williams AD, Carey MF, Selig S, Hayes A, Krum H, Patterson J, Toia D, Hare DL. Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rate--a randomized controlled trial. J Card Fail 2007; 13: 79–85.
6. Szentesi P, Bekedam MA, van Beek-Harmsen BJ, van der Laarse WJ, Zaremba R, Boonstra A, Visser FC, Stienen GJ. Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure. J Appl Physiol 2005; 99: 2189–95.
7. Näveri HK, Leinonen H, Kiilavuori K, Härkönen M. Skeletal muscle lactate accumulation and creatine phosphate depletion during heavy exercise in congestive heart failure. Cause of limited exercise capacity? Eur Heart J 1997; 18: 1937–45.
8. Doehner W, Rauchhaus M, Godsland IF, Egerer K, Niebauer J, Sharma R, Cicoira M, Florea VG, Coats AJS, Anker SD. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine and TNF-alpha. Int J Cardiol 2002; 83: 73–81.
9. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DA, Leyva F, Proudler T, Coats AJ, Anker SD, Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005; 46: 1019–26.
10. Simoneau JA, Colberg SR, Leland Thaete F, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB 1995; 9:273–278.
11. Del Prato S, Bonadonna RC, Bonora E, Gulli G, Solini A, Shank M, DeFronzo RA. Characterisation of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 1993; 91:484–94.
12. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet 2004; 364: 1786–8.
13. Doehner W, Gathercole D, Cicoira M, Krack A, Coats AJ, Camici PG, Anker SD. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol 2010; 138: 19–24.
14. Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 1993; 125: 1494–7.
15. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise tolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984; 69: 1079–1087.
16. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667–E677.
17. Swan JW, Walton C, Godsland IF. Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure. Clin Sci 1994; 86: 317–322.
18. Doehner W, Anker SD, Godsland IF Optimising insulin sensitivity assessment using the modelling method in chronic heart failure. Horm Metab Res 2005; 37: 106–10.
19. Jones DA, Round JM, Edwards RHT, Grindrod SR, Tofts PS. Size and composition of the calf and quadriceps in Duchenne muscular dystrophy. J Neurol Sci 1983; 60: 307–22.
20. Volterrani M, Clark AL, Ludman PF, Swan JW, Adamopoulos S, Piepoli M, Coats AJ. Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994; 15: 801–809.
21. Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P, Claus RA, Anker SD. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 2007; 28: 821–8.
22. Cauchie P, Vertongen F, Bosson D, Dorchy H. Erythrocyte metabolic alterations in type I diabetes: relationship to metabolic control. Ann Biol Clin (Paris) 1992; 50: 9–13.
23. Ortmeyer HFK, Bodkin NL, Hansen BC. Relationship of skeletal muscle glucose-6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin resistant diabetic rhesus monkeys. Diabetologia 1994; 37: 127–33.
24. Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A, Tschoepe D, Doehner W, Greene SJ, Senni M, Gheorghiade M, Fonarow GC. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail 2015; 3: 136–145.
25. Sutton JR, Toews CJ, Ward GR, Fox IH. Purine metabolism during strenuous muscular exercise in man. Metabolism 1980; 29: 254–260.
26. Fox IH. Adenine triphosphate degradation in specific disease. J Lab Clin Med 1985; 106: 101–110.